Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7232)
All Articles published online
|
Publishing Process of This Article
|
Aug 12, 2015 (publication date) through May 12, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aceti A, Gianserra L, Lambiase L, Pennica A, Teti E. Pharmacogenetics as a tool to tailor antiretroviral therapy: A review. World J Virology 2015; 4(3): 198-208 [PMID: 26279982 DOI: 10.5501/wjv.v4.i3.198] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v4/i3/198.htm |
| Number | Citing Articles |
| 1 |
E. Elliot, T. Mahungu, A. Owen. Genetics and Evolution of Infectious Diseases. 2017; : 435 doi: 10.1016/B978-0-12-799942-5.00019-6
|
| 2 |
Jennifer L. Baker, Daniel Shriner, Amy R. Bentley, Charles N. Rotimi. The Genetics of African Populations in Health and Disease. 2019; : 95 doi: 10.1017/9781139680295.006
|
| 3 |
Yashwant Chavan, Tanushree Mitra, Sharad Pawar, Umakant Mahajan, Manasee Wadgaonkar, Amar Bhagwat, Hrishikesh Joshi, Suryakant Bangar, Parag Purohit, Amol Raut. Rapid detection of HLA-B*5701 allele by in-house developed tetra-primer amplification refractory mutation system PCR. Meta Gene 2017; 12: 150 doi: 10.1016/j.mgene.2017.03.006
|
| 4 |
Stefanie Klenke, Gudrun J. de Vries, Laura Schiefer, Nina Seyffert, Hagen S. Bachmann, Jürgen Peters, Ulrich H. Frey. Genetic contribution to PONV risk. Anaesthesia Critical Care & Pain Medicine 2020; 39(1): 45 doi: 10.1016/j.accpm.2019.04.012
|
| 5 |
Jessica Cusato, Sarah Allegra, Amedeo De Nicolò, Andrea Calcagno, Antonio D'Avolio. Precision medicine for HIV: where are we?. Pharmacogenomics 2018; 19(2): 145 doi: 10.2217/pgs-2017-0123
|
| 6 |
Vanessa S Mattevi, Carmela FS Tagliari. Pharmacogenetic considerations in the treatment of HIV. Pharmacogenomics 2017; 18(1): 85 doi: 10.2217/pgs-2016-0097
|
| 7 |
Upal Roy, Vadym Drozd, Andriy Durygin, Jesse Rodriguez, Paul Barber, Venkata Atluri, Xiaohua Liu, Thomas G. Voss, Surendra Saxena, Madhavan Nair. Characterization of Nanodiamond-based anti-HIV drug Delivery to the Brain. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-017-16703-9
|
| 8 |
Daiani Cristina Cilião Alves, Rodrigo Haddad, Maurício Cristiano Rocha-Júnior, Virgínia Mara de Deus Wagatsuma, Gustavo Martelli-Palomino, Adriana Aparecida Marques, Osvaldo Massaiti Takayanagui, Dimas Tadeu Covas, Simone Kashima, Eduardo Antônio Donadi.
HLA-G 3′-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy/tropical spastic paraparesis development.
Journal of General Virology
2016; 97(10): 2742 doi: 10.1099/jgv.0.000559
|
| 9 |
Adekunle A. Bakare, Kehinde M. Akinseye, Bayonle A. Aminu, Francis C. Ofoegbu, Saheed O. Anifowose, Stork Abruda, Opeoluwa M. Fadoju, Olusegun I. Ogunsuyi, Ifeoluwa T. Oyeyemi, Okunola A. Alabi, Olusola M. Adetona, Chibuisi G. Alimba. Genetic and reproductive toxicity of lamivudine, tenofovir disoproxil fumarate, efavirenz and their combination in the bone marrow and testicular cells of male mice. Annals of Science and Technology 2020; 5(1): 1 doi: 10.2478/ast-2020-0001
|
| 10 |
Gianluca Russo, Giacomo Maria Paganotti, Sandra Soeria-Atmadja, Miriam Haverkamp, Doreen Ramogola-Masire, Vincenzo Vullo, Lars Lennart Gustafsson. Pharmacogenetics of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in resource-limited settings: Influence on antiretroviral therapy response and concomitant anti-tubercular, antimalarial and contraceptive treatments. Infection, Genetics and Evolution 2016; 37: 192 doi: 10.1016/j.meegid.2015.11.014
|
| 11 |
Jonathan Grant Peter, Rannakoe Lehloenya, Sipho Dlamini, Kimberly Risma, Katie D. White, Katherine C. Konvinse, Elizabeth J. Phillips. Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice. The Journal of Allergy and Clinical Immunology: In Practice 2017; 5(3): 547 doi: 10.1016/j.jaip.2017.01.025
|
| 12 |
Kevin S. O'Connell, Marelize Swart, Nathaniel W. McGregor, Collet Dandara, Louise Warnich. Pharmacogenetics of Antiretroviral Drug Response and Pharmacokinetic Variations in Indigenous South African Populations. OMICS: A Journal of Integrative Biology 2018; 22(9): 589 doi: 10.1089/omi.2018.0117
|
| 13 |
Bruno Toson, Rafael T. Michita, Maria C. T. Matte, Robson Soares, Gabriela K. S. Lawisch, Vanessa S. Mattevi, José A. B. Chies. Assessment of NKG2C copy number variation in HIV-1 infection susceptibility, and considerations about the potential role of lacking receptors and virus infection. Journal of Human Genetics 2022; 67(8): 475 doi: 10.1038/s10038-022-01029-w
|
| 14 |
Mohammed Auwal Ibrahim, Temitope O. Sogbanmu, Oluwasola E. Omoju, Kingsley N. Ukwaja. A Solution-Based Position Paper of the Nigerian Young Academy on Sex-for-Grades Menace Across Nigerian Tertiary Institutions. Annals of Science and Technology 2020; 5(1): 66 doi: 10.2478/ast-2020-0008
|
| 15 |
M. Neely, N.Y. Rakhmanina. Individualized Drug Therapy for Patients. 2017; : 207 doi: 10.1016/B978-0-12-803348-7.00014-9
|
| 16 |
Ayush Sharma, Prakash Kumar, Siddhartha Dutta, Rimple Jeet Kaur, Jaykaran Charan, Gaurav Chikara, Krishna Murti, Murali Kumarasamy, M. Ramesh, Krishna Pandey, V. Ravichandiran, Sameer Dhingra. Pathophysiological and Genetic Basis of Tenofovir-Induced Acute Renal Dysfunction: Strategies and Recent Developments for Better Clinical Outcomes. Current Pharmacology Reports 2022; 8(6): 427 doi: 10.1007/s40495-022-00304-w
|
| 17 |
Riaan Reay, Michelle Viljoen, Malie Rheeders. The Impact of Certain Pharmacogenetic Differences on the Metabolism of
Antiretroviral Drugs Used in A Black South African Population. Current Drug Metabolism 2023; 24(10): 700 doi: 10.2174/0113892002255240231117072211
|
| 18 |
E. Jennifer Edelman, Christopher T. Rentsch, Amy C. Justice. Polypharmacy in HIV: recent insights and future directions. Current Opinion in HIV and AIDS 2020; 15(2): 126 doi: 10.1097/COH.0000000000000608
|
| 19 |
Surulivelrajan Mallayasamy, Scott R. Penzak. Pharmacogenomics. 2019; : 227 doi: 10.1016/B978-0-12-812626-4.00008-5
|
| 20 |
Zinhle Cindi, Aida N. Kawuma, Gary Maartens, Yuki Bradford, Simiso Sokhela, Nomathemba Chandiwana, Willem D. Francois Venter, Roeland E. Wasmann, Paolo Denti, Lubbe Wiesner, Marylyn D. Ritchie, David W. Haas, Phumla Sinxadi. Pharmacogenetics of tenofovir clearance among Southern Africans living with HIV. Pharmacogenetics and Genomics 2023; 33(4): 79 doi: 10.1097/FPC.0000000000000495
|
| 21 |
J L Baker, D Shriner, A R Bentley, C N Rotimi. Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa. The Pharmacogenomics Journal 2017; 17(2): 112 doi: 10.1038/tpj.2016.78
|